CV Sciences, Inc.
CVSI· OTC
Released Mar 26, 2026, after the close
10-K filed Mar 26, 2026, 85 days after period end · 0001193125-26-126598
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $3.31M | $3.88M | $3.80M | $3.87M |
| Net Income | -$206.00K |
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
| -$726.00K |
| -$869.00K |
| -$2.31M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.